成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

(R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride

(R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride Struktur
2097061-03-3
CAS-Nr.
2097061-03-3
Englisch Name:
(R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride
Synonyma:
(R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride
CBNumber:
CB63384172
Summenformel:
C11H23ClN2O2
Molgewicht:
250.77
MOL-Datei:
2097061-03-3.mol

(R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride Eigenschaften

Sicherheit

(R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

(R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323658 +86-18168183658
sales1@artkmedchem.com China 39004 58
JW & Y Pharmlab Co., Ltd. 021-64340559 13651849907;
xinyu_shi@jwypharmlab.com.cn China 12036 58
Shanghai WangFa Chemical Technology Co., Ltd. 13918479294
xiebenfa@163.com China 3444 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
malulu@leyan.com China 54986 58
Shanghai Aizikang Pharmaceutical Research Co., Ltd 18721109360
306685371@qq.com China 1886 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
sales_china@pharmablock.com China 9786 58
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973130 17801761073
Gsiyu@solarbio.com China 50464 58
Shanghai Kaisen Biotechnology Co., Ltd 17558870519
3549952815@qq.com China 2999 58

  • (R)-(4,4-Dimethyl-pyrrolidin-3-yl)-carbamic acid tert-butyl ester hydrochloride
  • 2097061-03-3
Copyright 2019 ? ChemicalBook. All rights reserved